Matches in Nanopublications for { ?s ?p "[Indeed, the BCR-ABL1 fusion product is a target against which many tyrosine kinase inhibitors (TKIs) have been proven to be effective in the treatment of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Indeed, the BCR-ABL1 fusion product is a target against which many tyrosine kinase inhibitors (TKIs) have been proven to be effective in the treatment of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Indeed, the BCR-ABL1 fusion product is a target against which many tyrosine kinase inhibitors (TKIs) have been proven to be effective in the treatment of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1053246.RAI8weow6RDpd7oOep6VHBz7CW9oYxCdZugzVt20SsQJM130_assertion description "[Indeed, the BCR-ABL1 fusion product is a target against which many tyrosine kinase inhibitors (TKIs) have been proven to be effective in the treatment of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053246.RAI8weow6RDpd7oOep6VHBz7CW9oYxCdZugzVt20SsQJM130_provenance.
- NP1053247.RA7-cYnB3GghXUV80OYdJeqbkvu0gdjUWhGyobq0xtAFk130_assertion description "[Indeed, the BCR-ABL1 fusion product is a target against which many tyrosine kinase inhibitors (TKIs) have been proven to be effective in the treatment of CML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053247.RA7-cYnB3GghXUV80OYdJeqbkvu0gdjUWhGyobq0xtAFk130_provenance.